FILTER
FILTERED INTERVIEW RESULTS
Duane Nelson
CEO AND DIRECTOR, ENVIROLEACH
EnviroLeach offers gold miners an alternative for cyanide and explores recycling techniques
Denver Dreyer
CEO, WORLEYPARSONS RSA
WorleyParsons is an engineering company that provides project delivery and consulting services to the resources and energy sectors, and complex process industries.
Philippe Cloutier
CEO, CARTIER RESOURCES
Cartier Resources is a junior gold exploration company focused on the Abitibi greenstone belt in Quebec.
Dean Journeaux
COFOUNDER AND BOARD MEMBER, NEW MILLENNIUM IRON (NML)
New Millennium Iron Corp. (NML) has actively explored properties in Canada's Labrador Trough and is now at the development stage.
Suresh Vadnagra
EXECUTIVE GM OPERATIONS AMERICAS, MMG; PRESIDENT, MINERA LAS BAMBAS
A look at the plan for Las Bambas, a 1st tier, world-class asset and MMG’s flagship operation.
Andrew Wilkins
VICE PRESIDENT, BUSINESS DEVELOPMENT AND MARKETING, DISTRIBUTED GAS SOLUTIONS CANADA (DGSC)
DGSC works with mining companies to provide customized supply solutions for dis-tributed Liquefied Natural Gas (LNG) and Compressed Natural Gas (CNG) across Canada.
Paul Murphy
MANAGER SOUTH AMERICA, MINING PLUS
Mining Plus, which provides technical services around the world, is growing its South American presence.
Dominique Doucet
FOUNDER & CEO, SIRIOS RESOURCES
Pioneers in the discovery of world-class gold deposits in the James Bay region, Sirios has discovered numerous showings in Nord-du-Québec and Eastern Canada.
Maname Fall
MANAGER & ASSOCIATE, SOJUFISC
SOJUFISC is a Senegalese law firm focused on supporting business in natural resources.
Bill Xue
PRESIDENT & CEO, WESTERN RESOURCES
TSX-listed Western Resources’ wholly owned subsidiary Western Potash Corp is fo-cused on developing the Milestone potash project in Saskatchewan.
MACIG
SPANISH
SUBSCRIBE TO OUR NEWSLETTER
RECENT PUBLICATIONS
United States Life Sciences 2025 - Digital Interactive
Resilience amid uncertainty. These words encapsulate the US life sciences sector as it navigates 2025. While the industry has largely rebounded from the recent biotech bear market, with clinical trial starts and funding showing signs of rebound, headwinds remain.
Resilience amid uncertainty. These words encapsulate the US life sciences sector as it navigates 2025. While the industry has largely rebounded from the recent biotech bear market, with clinical trial starts and funding showing signs of rebound, headwinds remain.
PARTNER EVENTS
SUBSCRIBE TO OUR
NEWSLETTER
- Get GBR content delivered to your inbox
- Receive industry based news
- Completely free, e-mail only
